概括
敏感的3T3纤维细胞在生长停止时分化为脂肪细胞. 序列选择可以产生具有高脂肪转化频率的亚克隆,这是由于影响敏感性的遗传性变化造成的.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 纤维细胞分化成脂肪细胞是脂肪组织发育的关键过程.
- 3T3纤维细胞作为研究脂肪生成的模型系统.
研究的目的:
- 研究3T3纤维细胞中脂肪转化的频率和机制.
- 探索遗传性变化对脂肪生成易感性的作用.
主要方法:
- 3T3纤维细胞的细胞培养.
- 具有不同脂肪转化频率的子克隆的连续选择.
- 在分化过程中对细胞形态的显微观测.
主要成果:
- 敏感的3T3纤维细胞在生长停止后分化为脂肪细胞.
- 脂肪细胞的形成发生在群体中,表明克隆起源.
- 序列选择成功生成了具有显著增加脂肪转化频率的亚克隆.
- 遗传性变化,可能涉及调节甘油三合成,是增加易感性的基础.
结论:
- 在3T3纤维细胞中,脂肪酸转化受影响于影响细胞易感性的遗传因素.
- 自发的,可遗传的变化可以导致增强的脂肪生成.
- 脂肪转化过程涉及明显的形态变化,包括甘油三积累和细胞圆形化.
更多相关视频
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
2.3K
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.8K
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cellular Adaptation III: Hyperplasia
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
